Literature DB >> 33572632

Gender Differences in the Risk of Ischemic Heart Disease According to Healthcare Utilization and Medication Adherence among Newly Treated Korean Hypertensive Patients.

Jiae Shin1, Dongwoo Ham2, Hee Young Paik3, Sangah Shin4, Hyojee Joung1,2.   

Abstract

We aimed to investigate gender differences in ischemic heart disease (IHD) according to healthcare utilization and medication adherence among newly treated Korean hypertensive adults. The National Sample Cohort version 2.0 of the National Health Insurance Service was used for analysis. Newly treated hypertensive patients ≥ 20 years and without IHD in 2002 were selected from a population that underwent health examination during 2003-2006. Of those patients, 11,942 men and 11,193 women were analyzed and followed up for 10 years. We determined the association between IHD and healthcare utilization and medication adherence using the Cox proportional hazards model. Hypertensive women patients had a lower risk of IHD than men patients (hazard ratio [HR] = 0.93, 95% confidence interval [CI] 0.88-1.00). The IHD risk was increased in patients who visited healthcare providers > 12 times/person-year (HR = 2.97, 95% CI 2.79-3.17), paid high out-of-pocket expense/person-year (HR = 1.55, 95% CI 1.41-1.69), and had medication nonadherence (HR = 1.67, 95% CI 1.58-1.77). However, the risk was decreased in patients who used both urban and rural areas (HR 0.75, 95% CI 0.67-0.84) and mixed types of providers (HR = 0.93, CI 0.88-0.99). The risk of IHD was significantly different between men and women only in the visiting frequency to healthcare providers (men, HR = 3.21, 95% CI 2.93-3.52; women, HR = 2.78, 95% CI 2.53-3.04, p for interaction = 0.0188). In summary, the risk of IHD was similar according to healthcare utilization and medication adherence between men and women, except visiting frequency to healthcare providers.

Entities:  

Keywords:  National Health Insurance Service; gender differences; healthcare utilization; ischemic heart disease; medication adherence

Year:  2021        PMID: 33572632      PMCID: PMC7908180          DOI: 10.3390/ijerph18031274

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  36 in total

1.  Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.

Authors:  Juneyoung Lee; Ji Sung Lee; Sook-Hee Park; Soon Ae Shin; KeeWhan Kim
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

2.  Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension.

Authors:  Cairu Li; Gunnar Engström; Bo Hedblad; Lars Janzon
Journal:  J Hypertens       Date:  2006-08       Impact factor: 4.844

3.  Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.

Authors:  R P Donahue; J M Dorn; S Stranges; M Swanson; K Hovey; M Trevisan
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-03-15       Impact factor: 4.222

4.  The total lifetime costs of smoking.

Authors:  Susanne R Rasmussen; Eva Prescott; Thorkild I A Sørensen; Jes Søgaard
Journal:  Eur J Public Health       Date:  2004-03       Impact factor: 3.367

5.  Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.

Authors:  Qiuping Gu; Vicki L Burt; Ryne Paulose-Ram; Charles F Dillon
Journal:  Am J Hypertens       Date:  2008-05-01       Impact factor: 2.689

6.  Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.

Authors:  Sukyoun Shin; Hyunjong Song; Sang-Kwon Oh; Kyung Eob Choi; Ho Kim; Sunmee Jang
Journal:  Hypertens Res       Date:  2013-08-22       Impact factor: 3.872

7.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

8.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

9.  Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension.

Authors:  Hyun-Jin Kim; Seok-Jun Yoon; In-Hwan Oh; Jae Hee Lim; Young Ae Kim
Journal:  Korean Circ J       Date:  2016-04-26       Impact factor: 3.243

10.  An upper and lower bound of the Medication Possession Ratio.

Authors:  Christian M Sperber; Suren R Samarasinghe; Grace P Lomax
Journal:  Patient Prefer Adherence       Date:  2017-08-30       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.